Yuhang Pharmaceutical (002437.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 248 million, up 1.8% year on year.

Zhitong Finance APP News, Yuheng Pharmaceutical (002437.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 1.427 billion yuan, a year-on-year decrease of 14.3%; net profit attributable to shareholders of the listed company was 248 million yuan, a year-on-year increase of 1.8%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 199 million yuan, a year-on-year increase of 11.74%; basic earnings per share were 0.1127 yuan.